ADAR1 Capital Management »

Oaktree Acquisition Corp Iii shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Oaktree Acquisition Corp Iii (OACCU) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Oaktree Acquisition Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Oaktree Acquisition Corp Iii held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oaktree Acquisition Corp Iii by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.5M 517k 10.61
2025-06-30 $5.5M 517k 10.61
2025-03-31 $5.4M 517k 10.44
2024-12-31 $5.1M 500k 10.13

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Oaktree Acquisition Corp Iii

ADAR1 Capital Management
Affinity Asset Advisors
Athos Capital
Clear Street
UBS Group

View all funds holding Oaktree Acquisition Corp Iii